Pharmaceutical

Pulmonary arterial hypertension market to reach $9.35bn across 7MM by 2034

The pulmonary arterial hypertension market is forecast to grow at a CAGR of 2.0% from 2024 to 2034, reaching $9.35bn across 7MM.

Jul 9, 2025 - 06:00
Pulmonary arterial hypertension market to reach $9.35bn across 7MM by 2034
The pulmonary arterial hypertension market is forecast to grow at a CAGR of 2.0% from 2024 to 2034, reaching $9.35bn across 7MM.
Read the original article

Tags:

Previous Article

Leading medical groups sue RFK Jr and HHS over ‘hostile’ vaccine policies

Next Article

Swissmedic approves Novartis’ malaria medicine for babies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Schizophrenia gene found to be linked to energy dysfunction in brain cells

STAT+: Schizophrenia gene found to be linked to energy ...

Aug 17, 2023

Biocytogen and Radiance partner for bispecific antibody-drug conjugate

Biocytogen and Radiance partner for bispecific antibody...

Jan 9, 2024

Rollout of Covid vaccines is bumpy, but not unexpected, experts say

Rollout of Covid vaccines is bumpy, but not unexpected,...

Sep 26, 2023